Pharmaceutical News and Articles

Tourette Syndrome Often Overlooked in Girls

about 6.5 years old versus 6 years old for boys, results show.Prompt detection of Tourette syndrome is important to help people manage the condition, Dy-Hollins

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

SAN DIEGO January 10, 2025 Crinetics Pharmaceuticals, Inc. (Nasdaq CRNX) today announced positive topline results from an open-label, Phase 2 congenital adrenal

Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)

(Newsfile Corp. - January 13, 2025) - Adaptimmune Therapeutics plc (NASDAQ ADAP), a company working to redefine the treatment of solid tumor cancers with cell t

Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo (axatilimab-csfr) 9 mg and 22 mg Vial Sizes

Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo (tabelecleucel)

Psychological Distress in Teen Years Tied to Later Economic Outcomes

Psychological distress in adolescence is tied to economic outcomes 10 years later, according to a study published online Jan. 16 in PLOS Medicine.Nathaniel Z. C

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

Job Strain Tied to New Sleep Disturbances Over Time

U.S. workers who report high job strain experience significantly more sleep disturbances over time, according to a study published online Jan. 8 in the American

FDA Proposes Nicotine Limits on Combustible Tobacco Products

The U.S. Food and Drug Administration has issued a proposed rule to lower the level of nicotine in cigarettes and certain other combustible tobacco products in

TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the addition of lenvatinib and pembrolizumab